Evogene Ltd. (EVGN)
NASDAQ: EVGN · IEX Real-Time Price · USD
0.612
-0.028 (-4.38%)
At close: Apr 19, 2024, 3:54 PM
0.620
+0.008 (1.31%)
After-hours: Apr 19, 2024, 5:03 PM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $30.96 million as of April 19, 2024. Its market cap has increased by 25.85% in one year.
Market Cap
30.96M
Enterprise Value
1.43M
1-Year Change
25.85%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since December 31, 2012, Evogene's market cap has decreased from $226.30M to $30.96M, a decrease of -86.32%. That is a compound annual growth rate of -16.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 19, 2024 | 31.00M | -4.32% |
| Apr 18, 2024 | 32.40M | -6.63% |
| Apr 17, 2024 | 34.70M | -1.98% |
| Apr 16, 2024 | 35.40M | 2.02% |
| Apr 15, 2024 | 34.70M | -7.71% |
| Apr 12, 2024 | 37.60M | - |
| Apr 11, 2024 | 37.60M | -4.08% |
| Apr 10, 2024 | 39.20M | -4.62% |
| Apr 9, 2024 | 41.10M | 3.01% |
| Apr 8, 2024 | 39.90M | 6.40% |
| Apr 5, 2024 | 37.50M | 0.27% |
| Apr 4, 2024 | 37.40M | -2.35% |
| Apr 3, 2024 | 38.30M | - |
| Apr 2, 2024 | 38.30M | -3.04% |
| Apr 1, 2024 | 39.50M | 4.22% |
| Mar 28, 2024 | 37.90M | 1.88% |
| Mar 27, 2024 | 37.20M | 0.81% |
| Mar 26, 2024 | 36.90M | -7.52% |
| Mar 25, 2024 | 39.90M | -0.50% |
| Mar 22, 2024 | 40.10M | 1.01% |
| Mar 21, 2024 | 39.70M | -1.98% |
| Mar 20, 2024 | 40.50M | - |
| Mar 19, 2024 | 40.50M | -0.98% |
| Mar 18, 2024 | 40.90M | -1.45% |
| Mar 15, 2024 | 41.50M | 7.24% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Co-Diagnostics | 35.64M |
| DarioHealth | 35.63M |
| ProMIS Neurosciences | 35.27M |
| LENSAR | 34.87M |
| Cyclo Therapeutics | 34.75M |
| BriaCell Therapeutics | 34.52M |
| Fortress Biotech | 34.05M |
| VYNE Therapeutics | 33.84M |